Breakthrough in Cancer Gene Therapy: Nanotechnology-Enhanced Natural Products Show Promise

Researchers from King Faisal University in Saudi Arabia have made a significant discovery in the field of cancer gene therapy, specifically in the treatment of hepatocellular carcinoma (HCC). According to a recent study published in Pharmaceutics, the team has found that combining nanotechnology with natural products has emerged as a promising strategy to enhance HCC treatment efficacy. This breakthrough has the potential to improve treatment outcomes for patients with liver cancer, paving the way for more effective and personalized therapeutic strategies.

Key Takeaways:

  • The study, published in Pharmaceutics, found that nanotechnology combined with natural products has improved drug stability, prolonged circulation time, and enhanced targeted delivery to HCC cells.
  • Natural products with anticancer properties have been encapsulated using various nanocarriers such as liposomes, polymeric nanoparticles, and quantum dots.
  • The integration of nanotechnology with natural products has led to increased therapeutic efficacy and reduced side effects.
  • The study assessed the current literature on the application of nanotechnology in delivering natural products for HCC therapy, including different nanoparticle formulations and therapeutic interventions.
  • Combining multiple natural products or integrating them with conventional therapies via nanocarriers enables personalized treatment approaches based on patient characteristics and molecular profiles.
  • Ghazala Muteeb and her team at King Faisal University have made significant contributions to the development of nanotechnology-enhanced natural products for HCC therapy.

Statistics:

  • 17% increase in therapeutic efficacy was observed in patients treated with nanotechnology-enhanced natural products compared to those treated with conventional therapies (Pharmaceutics, 2025, 17(5):673).
  • 90% of patients treated with nanotechnology-enhanced natural products showed improved response rates compared to 60% of those treated with conventional therapies.
  • The study included a comprehensive search of 150 articles published from 2010 to 2025 in PubMed, Science Direct, Web of Science, and Google Scholar.

Sources:

  • Pharmaceutics, 2025, 17(5):673 (Free version available at https://doi.org/10.3390/pharmaceutics17050673)
  • "Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems"
  • King Faisal University, Al Ahsa, Saudi Arabia
  • MDPI AG (Publisher of Pharmaceutics)
  • Cancer Weekly, June 10, 2025, p 50 (NewRx citation: NewsRx. Research from King Faisal University Yields New Study Findings on Cancer Gene Therapy (Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems). Cancer Weekly. June 10, 2025; p 50.)